New Biomimicry Control for COVID Diagnostics Improves Accuracy and Safety of Coronavirus Testing
A team of researchers have developed a unique “control standard” that improves accuracy and safety of COVID-19 testing by using biomimicry as a safer alternative to incorporating the actual SARS-COV-2 virus. More...03 Nov 2020
On-the-Go SARS-CoV-2 Testing Device Being Designed for Rapid Reporting of Results
An in vitro diagnostic device that is currently under development has the potential for testing by patients anywhere to allow public health professionals to immediately detect SARS-CoV-2 via a mobile device as an aid in the diagnosis of COVID-19 infection. More...03 Nov 2020
Moderna Preparing for Global Launch of COVID-19 Vaccine, Ready to Ship 20 Million Doses by 2020 End
Moderna, Inc. (Cambridge, MA, USA) is preparing for the global launch of its COVID-19 vaccine and has already received deposits of over USD 1 billion from governments around the world. More...02 Nov 2020
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Documentation System For Blood Banks
HettInfo II
New
Hospital Bed
Alphalite
In Other News
Fitness Trackers Can Predict COVID-19 Infections, Suggests Landmark Study
Moderna to Report Early Data from Ongoing COVID-19 Vaccine Trial in November
Regeneron's COVID-19 Antibody Cocktail Significantly Reduces Virus Levels in Ongoing Phase 2/3 Trial
More Than 90% of COVID-19 Patients Produce Strong Antibody Response to SARS-CoV-2 That Lasts for Many Months
Global COVID-19 Diagnostics Market to Reach USD 9.94 Billion by Fourth Quarter of 2020
New Technology Enables Touchless Respiratory and Heart Rate Measurement for COVID-19 Health Screening
Non-Invasive COVID-19 Test Identifies `Breath Signatures` to Provide Almost Instant Results
Designing COVID-19 Vaccine That Partially Mimics Structure Of SARS-CoV-2 Virus Could Increase Its Effectiveness
Novartis Collaborates with Molecular Partners AG to Develop Antiviral Therapies for Prevention and Treatment of COVID-19
New AI-Based Tool Rapidly and Automatically Determines Which COVID-19 Patients May Need Hospitalization
World’s Fastest PCR-Based SARS-CoV-2 Test Now Available on Randox-Bosch Vivalytic POC Analyzer
Discovery of Helpful and Harmful COVID-19-Related Genes to Aid Development of New Therapies
Finger-Prick Tests Show Antibody Response to SARS-CoV-2 Reduces Over Time
Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership
Study to Examine Whether Rapid COVID-19 Antigen Tests Can Identify Infectious and Asymptomatic Individuals
Ortho Launches New VITROS SARS-CoV-2 Antigen Test for Accurate Mass-Scale Testing in Markets Accepting CE Mark
DiaSorin Launches New LIAISON SARS-CoV-2 Ag High-Throughput Antigen Test in Markets Accepting CE Mark
AstraZeneca-Oxford COVID-19 Experimental Vaccine Triggers Similar Protective Antibodies and T-Cells in Both Older and Younger Adults
New Groundbreaking COVID-19 Test to Identify SARS-CoV-2 Virus Particles in Exhaled Breath Within Five Minutes
New Landmark Study Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
Inhaled Antibody from Convalescent COVID-19 Patients Could Be More Potent Treatment for SARS-Cov-2 Lung Infection
PerkinElmer’s Multianalyte SARS-CoV-2, Flu Test Receives CE Mark
CDC to Roll out Cell Phone-Based Surveillance System for Monitoring COVID-19 Vaccine Recipients
